Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications AN Vgontzas, EO Bixler, HM Lin, P Prolo, G Mastorakos, A Vela-Bueno, ... The Journal of Clinical Endocrinology & Metabolism 86 (8), 3787-3794, 2001 | 1074 | 2001 |
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans G Mastorakos, GP Chrousos, JS Weber The Journal of Clinical Endocrinology & Metabolism 77 (6), 1690-1694, 1993 | 752 | 1993 |
Maternal and fetal hypothalamic‐pituitary‐adrenal axes during pregnancy and postpartum G Mastorakos, I Ilias Annals of the New York Academy of Sciences 997 (1), 136-149, 2003 | 723 | 2003 |
Circadian interleukin-6 secretion and quantity and depth of sleep AN Vgontzas, DA Papanicolaou, EO Bixler, A Lotsikas, K Zachman, ... The Journal of Clinical Endocrinology & Metabolism 84 (8), 2603-2607, 1999 | 617 | 1999 |
Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline CM Gordon, KE Ackerman, SL Berga, JR Kaplan, G Mastorakos, M Misra, ... The Journal of Clinical Endocrinology & Metabolism 102 (5), 1413-1439, 2017 | 528 | 2017 |
Oxidative stress biomarkers responses to physical overtraining: implications for diagnosis K Margonis, IG Fatouros, AZ Jamurtas, MG Nikolaidis, I Douroudos, ... Free Radical Biology and Medicine 43 (6), 901-910, 2007 | 506 | 2007 |
Cushing's syndrome in children and adolescents--presentation, diagnosis, and therapy MA Magiakou, G Mastorakos, EH Oldfield, MT Gomez, JL Doppman, ... New England Journal of Medicine 331 (10), 629-636, 1994 | 506 | 1994 |
Exercise and the stress system G Mastorakos, M Pavlatou, E Diamanti-Kandarakis, GP Chrousos Hormones (Athens) 4 (2), 73-89, 2005 | 471 | 2005 |
Sleep deprivation effects on the activity of the hypothalamic–pituitary–adrenal and growth axes: potential clinical implications AN Vgontzas, G Mastorakos, EO Bixler, A Kales, PW Gold, GP Chrousos Clinical endocrinology 51 (2), 205-215, 1999 | 347 | 1999 |
Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome … G Mastorakos, JS Weber, MA Magiakou, H Gunn, GP Chrousos The Journal of Clinical Endocrinology & Metabolism 79 (4), 934-939, 1994 | 338 | 1994 |
Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time MA Magiakou, G Mastorakos, D Rabin, B Dubbert, PW Gold, ... The Journal of Clinical Endocrinology & Metabolism 81 (5), 1912-1917, 1996 | 307 | 1996 |
Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early … LJ Crofford, KT Kalogeras, G Mastorakos, MA Magiakou, J Wells, ... The Journal of Clinical Endocrinology & Metabolism 82 (4), 1279-1283, 1997 | 293 | 1997 |
Central serous chorioretinopathy in endogenous hypercortisolism EA Bouzas, MH Scott, G Mastorakos, GP Chrousos, MI Kaiser-Kupfer Archives of Ophthalmology 111 (9), 1229-1233, 1993 | 280 | 1993 |
p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies M Reincke, M Karl, WH Travis, G Mastorakos, B Allolio, HM Linehan, ... The Journal of Clinical Endocrinology & Metabolism 78 (3), 790-794, 1994 | 274 | 1994 |
The hypothalamic-pituitary-adrenal axis and the female reproductive system. MA Magiakou, G Mastorakos, E Webster, GP Chrousos Annals of the New York Academy of Sciences 816, 42-56, 1997 | 265 | 1997 |
The hypothalamic‐pituitary‐thyroid axis and the female reproductive system AG Doufas, G Mastorakos Annals of the New York Academy of Sciences 900 (1), 65-76, 2000 | 235 | 2000 |
Exercise as a stress model and the interplay between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axes G Mastorakos, M Pavlatou Hormone and Metabolic Research 37 (09), 577-584, 2005 | 234 | 2005 |
Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome G Valsamakis, C KANAKA‐GANTENBEIN, A MALAMITSI‐PUCHNER, ... Annals of the New York Academy of Sciences 1092 (1), 138-147, 2006 | 229 | 2006 |
Somatostatin analogues suppress the inflammatory reaction in vivo. K Karalis, G Mastorakos, GP Chrousos, G Tolis The Journal of clinical investigation 93 (5), 2000-2006, 1994 | 223 | 1994 |
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives G Mastorakos, C Koliopoulos, G Creatsas Fertility and sterility 77 (5), 919-927, 2002 | 221 | 2002 |